Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $98 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel has reiterated a Buy rating on Dolby Laboratories (NYSE:DLB) and maintained a price target of $98. This reaffirmation of confidence in Dolby's stock suggests a positive outlook on the company's performance.
December 11, 2023 | 3:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel has reiterated a Buy rating on Dolby Laboratories with a maintained price target of $98, indicating a positive outlook on the company's stock.
The reiteration of a Buy rating by a prominent analyst can have a positive impact on investor sentiment and potentially lead to a short-term increase in the stock price. The maintained price target of $98 suggests that the analyst sees continued upside potential in the stock, which could encourage investors to maintain or establish positions in DLB.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100